Patent ID: 6322780
Filing Date: 2001-11-27
Classification: A61K,A61P,C07K,C12N

Abstract:
A vaccine composition comprisinga recombinant virus comprising an isolated, purified DNA molecule comprising(a) the nucleotide sequence shown in SEQ ID NO:1, or a nucleotide sequence biologically functionally equivalent to SEQ ID NO: 1, and(b) gB antigen of Marek's disease virus or a polypeptide biologically functionally equivalent thereto; ora virus comprising(a) an isolated, purified DNA molecule comprising a nucleotide sequence encoding a polypeptide comprising the amino acid sequence as shown in SEQ ID NO:2, or comprising an amino acid sequence biologically functionally equivalent to SEQ ID NO: 2, and(b) gB antigen of Marek's disease virus or a polypeptide biologically functionally equivalent thereto;and a pharmaceutically acceptable carrier.